NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -71.15% | 50.27% | 56.65% | -82.55% | -20.35% |
| Total Depreciation and Amortization | 26.61% | 32.50% | 56.49% | -3.79% | -32.72% |
| Total Amortization of Deferred Charges | -59.16% | -54.39% | 55.83% | 186.97% | 48.04% |
| Total Other Non-Cash Items | 376.08% | -69.41% | -76.80% | 112.73% | 2,133.90% |
| Change in Net Operating Assets | -75.29% | -24.10% | -188.37% | 5,659.89% | -77.46% |
| Cash from Operations | -33.41% | 9.22% | -27.30% | 224.61% | -52.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -397.38% | -- | -85.82% | -35.58% | 29.35% |
| Total Debt Repaid | -3,070.83% | -919.61% | -927.08% | 17.65% | 0.00% |
| Issuance of Common Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 195.53% | 28.63% | 142.71% | -35.86% | 94.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 222.50% | 92.40% | -179.57% | 109.85% | 779.10% |
